Protalix is a publicly traded biotechnology company
(NYSE Amex: PLX),
that is producing recombinant therapeutic proteins through the ProCellEx™ plant cell system.
ABOUT US
Corporate Profile
Market Needs
Protalix Advantage
Management Team
Scientific Advisory Board
Press Room
Careers
TECHNOLOGY
ProCellEx Overview
Platform Technology
Protein Production
PRODUCT DEVELOPMENT
Glucocerebrosidase
Pipeline Products
PARTNERSHIPS
INVESTOR RELATIONS
Corporate Strategy
Management Team
Board of Directors
Stock Information
Corporate Governance
Filings
Press Releases
FAQs
PATIENTS
EVENT CALENDER
CONTACT US
Patients
Investor Relations
PRESS ROOM
PROTALIX BIOTHERAPEUTICS
2 Snunit St., Science Park,
POB 455, Carmiel 20100, Israel.
T: +972-4-9028100
F: +972-4-988-9489
E:
info@protalix.com
patient-info@protalix.com
© 2007 Protalix Biotherapeutics. All Rights Reserved.